Merrimack Pharmaceuticals, Inc.
USD15.14
+0.01 (+0.10%)
CEO
Gary L. Crocker
IPO Date
2012-03-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$15.15
Prev. Close
$15.13
Day Low
$15.14
Day High
$15.16
52W Low
$11.53
52W High
$15.89
Market Cap
$0.22B
Volume
0.92M
| -100.4 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -17.3% | -16.6% | 0.00 | 26.13 | -21.4 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -18.9% | -18.0% | 0.00 | 21.49 | -30.4 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -122.8% | -105.9% | 0.00 | 6.75 | -2.0 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -68.9% | -45.7% | 0.25 | 5.14 | -1.0 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 490.2% | 402.3% | 0.00 | 4.81 | 0.2 |
| 31 Dec 2016 | FY | 95.2% | -105.2% | 60.4% | -186.2% | -0.86 | 0.65 | -2.7 |
| 31 Dec 2015 | FY | 99.9% | -165.8% | 80.4% | -63.0% | -1.40 | 1.94 | -4.7 |
| 31 Dec 2014 | FY | 100.0% | -81.1% | 81.5% | -52.5% | -1.18 | 1.19 | -11.1 |
| -200.3 |
| 30 Sept 2023 | Q3 | 0.0% | 0.0% | -1.5% | -1.4% | 0.00 | 39.14 | -158.2 |
| 30 Jun 2023 | Q2 | 0.0% | 0.0% | -2.1% | -2.0% | 0.00 | 47.30 | -112.4 |
| 31 Mar 2023 | Q1 | 0.0% | 0.0% | -0.5% | -0.5% | 0.00 | 42.39 | -460.9 |
| 31 Dec 2022 | Q4 | 200.0% | 110.6% | -2.6% | -2.5% | 0.00 | 33.66 | -80.2 |
| 30 Sept 2022 | Q3 | 0.0% | 0.0% | -2.4% | -2.3% | 0.00 | 30.42 | -39.5 |
| 30 Jun 2022 | Q2 | 0.0% | 0.0% | -3.4% | -3.3% | 0.00 | 31.85 | -43.2 |
| 31 Mar 2022 | Q1 | 0.0% | 0.0% | -0.9% | -0.9% | 0.00 | 25.91 | -160.8 |
| 31 Dec 2021 | Q4 | 0.0% | 0.0% | -3.3% | -3.2% | 0.00 | 26.13 | -27.6 |